Skip to Main Content

Paper Details

Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.
Biochem Biophys Res Commun
17
2018
A1, BRAF, BRAF-, BRAF-V600E, BRAF-V600E-negative melanoma, Melanoma, PDOX, PDOX model, S, S. typhimurium, Salmonella typhimurium, TEM, cancer, melanoma, metastatic melanoma, mice, mouse, o, o-rMETase, patient, rMETase, recombinant methioninase, temozolomide, tumor
Author NameAffiliation
Bartosz ChmielowskiUniversity of California los angeles
Scott D NelsonUniversity of California los angeles
Sarah M DryUniversity of California los angeles
Arun S SinghUniversity of California los angeles
Fritz C EilberUniversity of California los angeles
Robert M HoffmanUniversity of California
  • 1 - 6

Datasets

Release 1.2